Cover Image
市場調查報告書

臨床試驗市場分析:各階段,各研究設計,各適應症,各市場區隔的預測

Clinical Trials Market Analysis By Phase (Phase I/II/III/IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune, Pain management, Oncology, CNS condition, Diabetes, Obesity), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 557173
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床試驗市場分析:各階段,各研究設計,各適應症,各市場區隔的預測 Clinical Trials Market Analysis By Phase (Phase I/II/III/IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune, Pain management, Oncology, CNS condition, Diabetes, Obesity), And Segment Forecasts, 2014 - 2025
出版日期: 2017年08月08日 內容資訊: 英文 110 Pages
簡介

本報告提供全球臨床試驗市場相關調查分析,市場概要,各市場區隔的市場預測,競爭情形,主要企業等相關的系統性資訊。

第1章 調查手法、範圍

第2章 摘要整理

第3章 臨床試驗市場變數、趨勢、範圍

  • 市場區隔、範圍
  • 市場的推動要素分析
  • 市場的阻礙要素分析
  • 普及率、成長預測製圖
  • SWOT分析
  • 波特的五力分析

第4章 臨床試驗市場:各階段預測、趨勢分析

  • 趨勢分析
  • 階段I
  • 階段II
  • 階段III
  • 階段IV

第5章 臨床試驗市場:各研究設計預測、趨勢分析

  • 趨勢分析
  • 介入
  • 觀察
  • 利用範圍擴大

第6章 臨床試驗市場:各適應症預測、趨勢分析

  • 趨勢分析
  • 自體免疫/發炎
  • 疼痛管理
  • 腫瘤
  • 中樞神經系統疾病
  • 糖尿病
  • 肥胖
  • 心血管
  • 其他

第7章 臨床試驗市場:各地區的預測、趨勢分析

  • 趨勢分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 企業簡介
    • QuintilesIMS
    • Parexel International Corporation
    • Pharmaceutical Product Development, LLC
    • Charles River Laboratory
    • ICON Plc
    • Wuxi AppTec Inc.
    • PRA Health Sciences
    • Chiltern International Ltd.
    • INC Research
    • SGS SA
目錄
Product Code: GVR-1-68038-975-3

The global clinical trials market is expected to reach USD 65.2 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials.

Globalization of clinical trial has led to increase in investment in new product development in emerging countries thereby, having a positive impact on overall market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the life for mid-size and small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource what they think is beyond their core expertise. For instance, Pfizer currently has three CROs working with it to enhance its product portfolio and drive innovation. According to the partnership agreement with ICON in 2011, Pfizer would only preserve the scientific ownership for the trials and studies conducted by ICON, hence allowing the company to focus and further develop its capabilities in clinical trial designing.

Growing prevalence of disease and incidence of new disease is expected to give further boost to the clinical trial market. Worldwide population has varied disease profile with emerging countries having the most diverse disease profile. This is expected to boost the clinical trial of new or rare disease which otherwise would not have found any sponsors. More number of patients having a specific disease would act as a stimulus for biopharmaceutical companies to invest more in clinical trials for a disease segment.

Further key findings from the report suggest:

  • The global clinical trials market witnessed a lucrative growth in 2016 and is expected to grow at a CAGR of over 5.5% from 2017 to 2025
  • The market is expected to be dominated by Phase III as of 2016, with Phase I anticipated to witness the fastest growth
  • Increasing innovation and evolution of treatment is predicted to contribute towards growth of the expanded access trials segment
  • Based on indication, the oncology segment is anticipated to witness the fastest growth. According to various sources, more than USD 38.0 billion is currently being spent by the healthcare industry towards preclinical and clinical development of oncology therapy products
  • North America dominated the overall market in terms of revenue share in 2015 owing to the presence of big outsourcing firms and increasing R&D in the region.

Key players including Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA among the others dominate the global clinical trials market while representing maximum volume in 2016

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope & Assumptions
  • 1.3 List of Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Clinical Trials Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Globalization of clinical trials
      • 3.1.1.2 Adoption of new technology in clinical research
      • 3.1.1.3 Shift towards personalized medicine
      • 3.1.1.4 Growing disease variation and prevalence
      • 3.1.1.5 Increasing collaboration in biomedical research
      • 3.1.1.6 Growth in CRO market
  • 3.2 Market Restraint Analysis
      • 3.2.1.1 Regulations in new drug development
      • 3.2.1.2 Rising cost of clinical trials
      • 3.2.1.3 Pricing pressure
  • 3.3 Penetration & growth prospect mapping
  • 3.4 Clinical trials- SWOT Analysis, By Factor (political & legal, economic and social)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1 Clinical trials market: Phase movement analysis
  • 4.2 Clinical trials market: Phase movement analysis
  • 4.3 Phase I
  • 4.4 Phase II
  • 4.5 Phase III
  • 4.6 Phase IV

Chapter 5 Clinical Trials Market: Study Design Estimates & Trend Analysis

  • 5.1 Clinical trials market: Study Design movement analysis
  • 5.2 Clinical trials market: Study design movement analysis
  • 5.3 Interventional
  • 5.4 Observational
  • 5.5 Expanded access trials

Chapter 6 Clinical Trials Market: Indication Estimates & Trend Analysis

  • 6.1 Clinical trials market: Indication movement analysis
  • 6.2 Clinical trials market: Indication movement analysis
  • 6.3 Autoimmune/inflammation
    • 6.3.1 Global autoimmune based clinical trials market, 2014 - 2025 (USD Million)
    • 6.3.2 Rheumatoid arthritis
      • 6.3.2.1 Global rheumatoid arthritis based clinical trials market, 2014 - 2025 (USD Million)
    • 6.3.3 Multiple sclerosis
      • 6.3.3.1 Global multiple sclerosis based clinical trials market, 2014 - 2025 (USD Million)
    • 6.3.4 Osteoarthritis
      • 6.3.4.1 Global osteoarthritis based clinical trials market, 2014 - 2025 (USD Million)
    • 6.3.5 Irritable Bowel Disease (IBD)
      • 6.3.5.1 Global IBD based clinical trials market, 2014 - 2025 (USD Million)
    • 6.3.6 Others
      • 6.3.6.1 Global other disease based autoimmune clinical trials market, 2014 - 2025 (USD Million)
  • 6.4 Pain management
    • 6.4.1 Global pain management based clinical trials market, 2014 - 2025 (USD Million)
    • 6.4.2 Chronic pain
      • 6.4.2.1 Global chronic pain based clinical trials market, 2014 - 2025 (USD Million)
    • 6.4.3 Acute pain
      • 6.4.3.1 Global acute pain based clinical trials market, 2014 - 2025 (USD Million)
  • 6.5 Oncology
    • 6.5.1 Global oncology based clinical trials market, 2014 - 2025 (USD Million)
    • 6.5.2 Blood cancer
      • 6.5.2.1 Global blood cancer based clinical trials market, 2014 - 2025 (USD Million)
    • 6.5.3 Solid tumors
      • 6.5.3.1 Global solid tumors based clinical trials market, 2014 - 2025 (USD Million)
    • 6.5.4 Others
      • 6.5.4.1 Global other cancer based clinical trials market, 2014 - 2025 (USD Million)
  • 6.6 CNS conditions
    • 6.6.1 Global CNS conditions based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.2 Epilepsy
      • 6.6.2.1 Global epilepsy based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.3 Parkinson's Disease (PD)
      • 6.6.3.1 Global PD based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.4 Huntington's Disease (HD)
      • 6.6.4.1 Global HD based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.5 Stroke
      • 6.6.5.1 Global stroke based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.6 Traumatic Brain Injury (TBI)
      • 6.6.6.1 Global TBI based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.7 Amyotrophic Lateral Sclerosis (ALS)
      • 6.6.7.1 Global ALS based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.8 Muscle regeneration
      • 6.6.8.1 Global muscle regeneration based clinical trials market, 2014 - 2025 (USD Million)
    • 6.6.9 Others
      • 6.6.9.1 Global other disease based CNS clinical trials market, 2014 - 2025 (USD Million)
  • 6.7 Diabetes
    • 6.7.1 Global diabetes based clinical trials market, 2014 - 2025 (USD Million)
  • 6.8 Obesity
    • 6.8.1 Global Obesity based clinical trials market, 2014 - 2025 (USD Million)
  • 6.9 Cardiovascular
    • 6.9.1 Global cardiovascular based clinical trials market, 2014 - 2025 (USD Million)
  • 6.10 Other indications
    • 6.10.1 Global other indication based clinical trials market, 2014 - 2025 (USD Million)

Chapter 7 Clinical Trials Market: Regional Estimates & Trend Analysis, by Phase, Study Design, & Indication

  • 7.1 Clinical trials market share by region, 2016 & 2025
  • 7.2 North America
    • 7.2.1 North America clinical trials market, 2014 - 2025 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. clinical trials market, 2014 - 2025 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada clinical trials market, 2014 - 2025 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe clinical trials market, 2014 - 2025 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK clinical trials market, 2014 - 2025 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany clinical trials market, 2014 - 2025 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France clinical trials market, 2014 - 2025 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific clinical trials market, 2014 - 2025 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan clinical trials market, 2014 - 2025 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China clinical trials market, 2014 - 2025 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America clinical trials market, 2014 - 2025 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil clinical trials market, 2014 - 2025 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico clinical trials market, 2014 - 2025 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA clinical trials market, 2014 - 2025 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa clinical trials market, 2014 - 2025 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia clinical trials market, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 QuintilesIMS
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Parexel International Corporation
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Pharmaceutical Product Development, LLC
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Product Benchmarking
      • 8.1.3.3 Strategic Initiatives
    • 8.1.4 Charles River Laboratory
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 ICON Plc
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 Wuxi AppTec Inc.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Product Benchmarking
      • 8.1.6.3 Strategic Initiatives
    • 8.1.7 PRA Health Sciences
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Service Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Chiltern International Ltd.
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 INC Research
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 SGS SA
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Service Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • TABLE 1 North America clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 2 North America clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
  • TABLE 3 North America clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 4 North America. clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 5 North America clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 6 North America clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 7 North America clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
  • TABLE 8 North America clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 9 North America clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 10 North America clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 11 U.S. clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 12 U.S. clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 13 U.S. clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 14 U.S. clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 15 U.S. clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 16 U.S. clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 17 U.S. clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
  • TABLE 18 U.S. clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 19 U.S. clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 20 U.S. clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 21 U.S. clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 22 Canada clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 23 Canada clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 24 Canada clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 25 Canada clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 26 Canada clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 27 Canada clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 28 Canada clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
  • TABLE 29 Canada clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 30 Canada clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 31 Canada clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 32 Canada clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 33 Europe clinical trialmarket estimates and forecast by phase, 2014-2025
  • TABLE 34 Europe clinical trial market estimates and forecast by study design, 2014 - 2025
  • TABLE 35 Europe clinical trial market estimates and forecast by indication (USD Million)
  • TABLE 36 Europe clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 37 Europe clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 38 Europe clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 39 Europe clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
  • TABLE 40 Europe clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 41 Europe clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 42 Europe clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 43 Europe clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 44 U.K clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 45 U.K clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
  • TABLE 46 U.K clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 47 U.K clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 48 U.K clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 49 U.K clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 50 U.K clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 51 U.K clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 52 U.K clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 53 U.K clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 54 U.K clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 55 Germany clinical trial market estimates and forecast by phase, 2014 - 2025 (USD Million)
  • TABLE 56 Germany clinical trial market estimates and forecast by study design, 2014 - 2025
  • TABLE 57 Germany clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 58 Germany clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 59 Germany clinical trial pain management market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 60 Germany clinical trial oncology market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 61 Germany clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 62 Germany clinical trial diabetes market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 63 Germany clinical trial obesity market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 64 Germany clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 65 Germany clinical trial other market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 66 Asia Pacific clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 67 Asia Pacific clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
  • TABLE 68 Asia Pacific clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 69 Asia Pacific clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 70 Asia Pacific clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 71 Asia Pacific clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 72 Asia Pacific clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 73 Asia Pacific clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 74 Asia Pacific clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 75 Asia Pacific clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 76 Asia Pacific clinical trial other market estimates and forecast by indication, 2014-2025.
  • TABLE 77 China clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 78 China clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 79 China clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 80 China clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 81 China clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 82 China clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 83 China clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 84 China clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 85 China clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 86 China clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 87 China clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 88 Japan clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 89 Japan clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 90 Japan clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 91 Japan clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 92 Japan clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 93 Japan clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 94 Japan clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 95 Japan clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 96 Japan clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 97 Japan clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 98 Latin America other clinical trial market estimates and forecast by phases, 2014 - 2025(USD Million)
  • TABLE 99 Latin America clinical trial market estimates and forecast by study design, 2014 - 2025
  • TABLE 100 Latin America clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 101 Latin America clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 102 Latin America clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 103 Latin America clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 104 Latin America clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 105 Latin America trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 106 Latin America clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 107 Latin America clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 108 Latin America clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 109 Brazil clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 110 Brazil clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 111 Brazil clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 112 Brazil clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 113 Brazil clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 114 Brazil clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 115 Brazil clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 116 Brazil trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 117 Brazil clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 118 Brazil clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 119 Brazil clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 120 Mexico clinical trial market estimates and forecast by phase, 2014 - 2025 (USD Million)
  • TABLE 121 Mexico clinical trial market estimates and forecast by study design, 2014 - 2025
  • TABLE 122 Mexico clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
  • TABLE 123 Mexico clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 124 Mexico clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 125 Mexico clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 126 Mexico clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 127 Mexico trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 128 Mexico clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 129 Mexico clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 130 Middle East Asia clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 131 Middle East Asia clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
  • TABLE 132 Middle East Asia clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 133 Middle East Asia clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 134 Middle East Asia clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 135 Middle East Asia clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 136 Middle East Asia clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 137 Middle East Asia trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 138 Middle East Asia clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 139 Middle East Asia clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 140 Middle East Asia clinical trial other market estimates and forecast by indication, 2014 - 2025
  • TABLE 141 South Africa clinical trial market estimates and forecast by phase, 2014 - 2025
  • TABLE 142 South Africa clinical trial market estimates and forecast by study design (USD Million)
  • TABLE 143 South Africa clinical trial market estimates and forecast by indication, 2014 - 2025
  • TABLE 144 South Africa clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
  • TABLE 145 South Africa clinical trial pain management market estimates and forecast by indication, 2014 - 2025
  • TABLE 146 South Africa clinical trial oncology market estimates and forecast by indication, 2014 - 2025
  • TABLE 147 South Africa clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
  • TABLE 148 South Africa trial diabetes market estimates and forecast by indication, 2014 - 2025
  • TABLE 149 South Africa clinical trial obesity market estimates and forecast by indication, 2014 - 2025
  • TABLE 150 South Africa clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
  • TABLE 151 South Africa clinical trial other market estimates and forecast by indication, 2014 - 2025

List of Figures

  • FIG. 1 Market summary, 2016 (USD Million)
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Pharmaceutical R&D spending, 2007 - 2012 (USD Billion)
  • FIG. 6 Market restraint relevance analysis (Current & future impact)
  • FIG. 7 Penetration & growth prospect mapping
  • FIG. 8 SWOT Analysis, By Factor (political & legal, economic and social)
  • FIG. 9 Porter's Five Forces Analysis
  • FIG. 10 Clinical trials market phase outlook key takeaways
  • FIG. 11 Clinical trials market: Phase movement analysis
  • FIG. 12 Global phase I market, 2014 - 2025 (USD Million)
  • FIG. 13 Global phase II market, 2014 - 2025 (USD Million)
  • FIG. 14 Global phase III market, 2014 - 2025 (USD Million)
  • FIG. 15 Global phase IV market, 2014 - 2025 (USD Million)
  • FIG. 16 Clinical trials market study design outlook key takeaways
  • FIG. 17 Clinical trials market: Study design movement analysis
  • FIG. 18 Global interventional market, 2014 - 2025 (USD Million)
  • FIG. 19 Global observational market, 2014 - 2025 (USD Million)
  • FIG. 20 Global expanded access trials market, 2014 - 2025 (USD Million)
  • FIG. 21 Clinical trials market indication outlook key takeaways
  • FIG. 22 Clinical trials market: Indication movement analysis
  • FIG. 23 Global autoimmune based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 24 Global rheumatoid arthritis based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 25 Global multiple sclerosis based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 26 Global osteoarthritis based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 27 Global IBD based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 28 Global other disease based autoimmune clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 29 Global pain management based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 30 Global chronic pain based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 31 Global acute pain based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 32 Global oncology based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 33 Global blood cancer based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 34 Global solid tumors based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 35 Global other cancer based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 36 Global CNS conditions based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 37 Global epilepsy based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 38 Global PD based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 39 Global HD based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 40 Global stroke based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 41 Global TBI based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 42 Global ALS based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 43 Global muscle regeneration based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 44 Global other disease based CNS clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 45 Global diabetes based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 46 Global Obesity based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 47 Global cardiovascular based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 48 Global other indication based clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 49 Regional market place: Key takeaways
  • FIG. 50 Regional outlook, 2016 & 2025
  • FIG. 51 North America clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 52 U.S. clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 53 Canada clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 54 Europe clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 55 UK clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 56 Germany clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 57 France clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 58 Asia Pacific clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 59 Japan clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 60 China clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 61 Latin America clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 62 Brazil clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 63 Mexico clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 64 MEA clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 65 South Africa clinical trials market, 2014 - 2025 (USD Million)
  • FIG. 66 Saudi Arabia clinical trials market, 2014 - 2025 (USD Million)
Back to Top